Future Directions for Treating Stage 1B, Grade 3 Endometrial Cancer
David Barrington, MD, discusses the next steps for oncologists treating patients with stage 1B, grade 3 endometrial cancer.
Questions Remain Unanswered in Treating Stage 1B Grade 3 Endometrial Cancer
David Barrington, MD, discusses the results investigators found in determining treatment patterns and recommendations for patients with endometrial cancer.
Factors Influencing Treatment Options for Stage 1B Grade 3 Endometrial Cancer
David Barrington, MD, discusses the key takeaways regarding the factors associated with variation of adjuvant treatments for patients with stage 1B, grade 3 endometrial cancer.
Role of Molecular Testing in Stage 1B, Grade 3 Endometrial Cancer
David Barrington, MD, discusses his advice on molecular testing for patients with stage 1B, grade 3 endometrial cancer.
Discussing Adjuvant Therapy Options for Endometrial Cancer
David Barrington, MD, discusses adjuvant treatments that are currently available for patients with stage 1B, grade 3 endometrial cancer.
